Filing Details

Accession Number:
0001209191-23-048905
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-11 13:52:12
Reporting Period:
2023-09-07
Accepted Time:
2023-09-11 13:52:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE Pharmaceutical Preparations (2834) 272546083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1603347 Alan Theodore Huizenga C/O Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato CA 94949
Svp, Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-07 2,000 $21.00 25,777 No 4 M Direct
Common Stock Disposition 2023-09-07 2,000 $41.00 23,777 No 4 S Direct
Common Stock Disposition 2023-09-07 163 $38.34 23,614 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-09-07 2,000 $0.00 2,000 $21.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,000 2024-01-29 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023.
  2. Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions.
  3. 1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter.